Search results for

Scientists now have a fairly noninvasive way to test for Creutzfeldt-Jakob disease, a rare form of dementia. A similar test, they say, might offer earlier diagnoses of Parkinson's and Alzheimer's.

Russia is still making billions of dollars on oil exports since invading Ukraine. That crude is still flowing abroad thanks in part to a controversial group of oil traders.

You can't follow everything in Rio, but you want to catch the highlights. Here's a guide to the American athletes and events likely to produce the most memorable performances.

NPR's Audie Cornish talks with our regular political commentators E.J. Dionne of the Washington Post and Brooking Institution and David Brooks of The New York Times. They discuss the United Kingdom's vote to leave the European Union, Donald Trump's visit to Scotland and House Democrats' sit-in over gun control.

Listen to some newfound favorites, including an epic piano anthem by Florence + The Machine, an acoustic drive-by ballad from Oshima Brothers plus Kehlani's sassy new dance-floor bop.

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?

Though it feels like a mere sample of what's to come, the Memphis rapper's new EP presents her as a singular talent using her instrument as a megaphone for provocation and inspiration.

Justin Bieber released a sequel to his album Swag before listeners even had a chance to really sit with the original. The move is indicative of a broader trend.

California alone has spent billions in state funds over the last 14 years to support stem cell research. Scientists want another round of cash. So, what exactly did voters get for their money so far?

The nation watched in horror Friday as the scope of a tragedy in Newtown, Conn., became clear. As a visibly upset President Obama said at midafternoon,…